Blocking IL-1beta to slow down progression of ALS?
van der Meer
Jos W M
JW
Department of General Internal Medicine, Radboud University Nijmegen Medical Centre, Geert Grooteplein 8, 6525 GA, Nijmegen, The Netherlands. j.vandermeer@aig.umcn.nl
Simon
Anna
A
D000690:Amyotrophic Lateral Sclerosis / Q000201:enzymology / Q000209:etiology* / Q000473:pathology; D000818:Animals; D002986:Clinical Trials as Topic; D018450:Disease Progression; D006801:Humans; D053583:Interleukin-1beta / Q000378:metabolism*; D051379:Mice; D050505:Mutant Proteins / Q000737:chemistry / Q000378:metabolism; D013482:Superoxide Dismutase / Q000737:chemistry / Q000378:metabolism; D000072105:Superoxide Dismutase-1
D053583:Interleukin-1beta; D050505:Mutant Proteins; C000606290:SOD1 protein, human; C000606291:Sod1 protein, mouse; D013482:Superoxide Dismutase; D000072105:Superoxide Dismutase-1